Objective To determine whether the experience of persistent epigastric pain is associated with sleep disturbances in children with eosinophilic esophagitis (EoE). We hypothesized that children with EoE and persistent epigastric pain would (1) self-report greater current and worst pain severity, and (2) experience more disturbed sleep on objective and subjective measures in comparison with children with EoE but no persistent pain and healthy children. Methods Fifty children with EoE were recruited for this cross-sectional study, of which 24 (48%) reported experiencing persistent epigastric pain. The remaining 26 (52%) children with EoE denied experiencing persistent pain. An additional 25 healthy children without EoE or persistent pain were included. All children provided severity ratings of current pain and worst pain experienced over the past week. Children then completed 12 consecutive nights of ambulatory sleep monitoring via actigraphy in the home. Caregivers provided information regarding their child's sleep patterns and internalizing symptoms. Results Children with EoE and persistent pain reported significantly greater severity of current pain (p < .001) and worst pain over the past week (p < .001) compared with EoE without persistent pain and healthy children. Compared with the other groups, children with EoE and persistent pain also demonstrated greater actigraphic sleep disturbances, lower sleep efficiency (p ¼ .004) and greater wake after sleep onset (p ¼ .034). Conclusions This study provides novel evidence that a significant proportion of children with EoE experience persistent symptoms of epigastric pain. Persistent pain was associated with significant sleep disturbances in children with EoE.
Introduction
Eosinophilic esophagitis (EoE) is a chronic inflammatory condition in which the wall of the esophagus becomes infiltrated with large numbers of eosinophils, which are pro-inflammatory white blood cells (Noel, Putnam, & Rothenberg, 2004; Potter et al., 2004) . Diagnosis requires identification of >15 eosinophils/ high-powered field (hpf) in the esophagus via endoscopy while on a proton-pump inhibitor (Liacouras et al., 2011 ). It appears that most cases of EoE are triggered by allergic hypersensitivity to foods. As such, pharmacological therapies (e.g., steroidal slurries) and dietary restriction are frequently combined as EoE treatments. EoE affects both adults and children; yet, it has only been recognized within the pediatric population over the past two decades.
Specifically as it relates to children, there is a mounting concern that the incidence of EoE is increasing above and beyond the recent diagnostic shift that has facilitated disease recognition (Cherian, Smith, & Forbes, 2006; Lee, Baker, Khan, & Baker, 2009) . Recent epidemiological research suggests that EoE is present in four to five pediatric cases per 10,000 American children (Dellon, Jensen, Martin, Shaheen, & Kappelman, 2014) .
Children with EoE typically present with a variety of gastrointestinal symptoms including dysphagia, reflux, nausea/vomiting, and epigastric pain, which taken together can promote feeding aversion (Liacouras et al., 2011) . Standard treatments for EoE have been shown to reduce the experience of certain symptoms like dysphagia, as well as improve the histological and microscopic presentation of the esophagus (Gonsalves et al., 2012; Guarino, Cicala, & Behar, 2016) . However, given its chronic nature, pediatric EoE often continues into adulthood (DeBrosse et al., 2011) . Without ongoing treatment, the risk of further EoE disease progression increases (Blanchard, Wang, & Rothenberg, 2006) , which may then necessitate more invasive interventions such as esophageal distention (Blanchard et al., 2006) .
Our group has previously suggested that persistent epigastric pain is a clinical symptom that is underappreciated and often undertreated in children with EoE (Lynch, Avis, Dimmitt, & Goodin, 2015) . Approximately 64-69% of children with EoE report chest and/or abdominal (i.e., epigastric) pain as a significant symptom (Butz et al., 2014; Klinnert et al., 2014) , with 61% reporting persistent pain, despite histologically determined disease remission (Butz et al., 2014; Pentiuk, Putnam, Collins, & Rothenberg, 2009 ). The current standard of care for pediatric EoE has little, if any, impact on the presentation or severity of epigastric pain (Butz et al., 2014; Gunasekaran et al., 2016) . Inappropriately managed pain in children can negatively affect their quality of life and psychosocial functioning (Hermann, Hohmeister, Demirakc¸a, Zohsel, & Flor, 2006) . In support of this notion, we have recently shown that, above all other clinical symptoms, persistent epigastric pain was predictive of poor health-related quality of life in children with EoE (Lynch et al., 2017) . One way that persistent pain can lead to poor quality of life in children with EoE is through the promotion of sleep disturbances.
Although extremely limited information is available regarding sleep patterns and disturbances in children with EoE, poor sleep quality has been identified as a concern by 25-33% of caregivers (Flood et al., 2008 , Straumann et al., 2012 when asked in interview what symptoms their child experiences. In pediatric populations with heterogeneous chronic pain conditions not including EoE, persistent pain has been found to lead to significant sleep disturbances including difficulty initiating and maintaining sleep, as well as poor sleep quality (Valrie, Bromberg, Palermo, & Schanberg, 2013) . In turn, sleep disturbances and poor sleep quality exacerbate the severity of persistent pain (Finan, Goodin, & Smith, 2013) . Sleep disturbances can have wide-ranging negative effects on a child's life beyond the experience of pain. For instance, disturbed sleep can lead to insufficient immune functioning, an overall slower healing process, and worsened atopic conditions, as well as diminished cognitive functioning, behavioral regulation and attention problems, poor academic performance, emotional lability, and relationship problems (Beebe, 2011; Bryant, Trinder, & Curtis, 2004; Sadeh, Gruber, & Raviv, 2003; Smaldone, Honig, & Byrne, 2007) .
Initial research addressing the psychological consequences of EoE has shown that internalizing symptoms consistent with depression and anxiety are experienced at higher rates in children with EoE when compared with their healthy peers (Cortina et al., 2010; Harris, Menard-Katcher, Atkins, Furuta, & Klinnert, 2013) . Depressive symptoms and anxiety can detrimentally affect a child's sleep (Chorney, Detweiler, Morris, & Kuhn, 2008; Palermo & Kiska, 2005) .
No study to date has examined whether the experience of persistent epigastric pain is associated with sleep disturbances in children with EoE. In an effort to address this gap in the literature, the current study compared the sleep of children with EoE and persistent epigastric pain with that of children with EoE not experiencing persistent pain and healthy controls without EoE or persistent pain. The severity of pain experienced by children with EoE and healthy controls was also assessed. Children's sleep was measured objectively using ambulatory monitoring (i.e., actigraphy) in the home environment, as well as subjectively according to caregiver-proxy reports. Current pain and worst pain severity over the past 7 days were measured using children's self-reports. We hypothesized that children with EoE and persistent epigastric pain would (1) self-report greater current and worst pain severity, and (2) experience more disturbed sleep on objective and subjective measures in comparison with children with EoE but no persistent pain and healthy control children. Initial research addressing the psychological consequences of EoE has shown that internalizing symptoms consistent with depression and anxiety are experienced at higher rates in children with EoE when compared with their healthy peers (Cortina et al., 2010; Harris, Menard-Katcher, Atkins, Furuta, & Klinnert, 2013) . Furthermore, depressive symptoms and anxiety can detrimentally affect a child's sleep (Chorney, Detweiler, Morris, & Kuhn, 2008; Palermo & Kiska, 2005) . Therefore, the current study collected caregiver-proxy reports of child's depressive symptoms and anxiety and included each as a statistical covariate in data analysis.
Methods

Participants
A total of 50 children with EoE between the ages of 4 and 12 years were recruited from a pediatric gastroenterology clinic as well as a family-focused eosinophilic disease conference at a large, tertiary children's hospital in the Deep South. An additional 25 healthy control children without EoE were also recruited from the hospital via posted fliers in primary care clinics and staff areas. A single caregiver for each child with EoE and healthy controls was also recruited to assist with questionnaire completion.
Children with EoE had a confirmed diagnosis defined as the presence of upper gastrointestinal tract symptoms (e.g., dysphagia, nausea/vomiting) and an endoscopy with !15 eosinophils/hpf in tissue biopsies of the proximal and/or distal esophagus according to consensus diagnostic recommendations (Dellon et al., 2013) . Exclusionary criteria for children with EoE included comorbid chronic illnesses (e.g., cystic fibrosis; cancer; short bowel syndrome; inflammatory bowel disease; epilepsy), sleep disorders, and chronic pain conditions (e.g., fibromyalgia; functional abdominal pain). Additionally, neurodevelopmental disorders (e.g., autism spectrum disorder) that could impact a child's ability to consistently and reliably collect ambulatory sleep data were also excluded from study participation. The gastroenterology physician for the EoE clinic assisted in the determination of patient's eligibility for the study, including evaluating for the presence of functional abdominal pain. Approximately 20% of participants eligible by age and EoE diagnoses were not eligible for the study because of other medical conditions.
Healthy control children were screened to rule out the presence of any eosinophilic disease, severe chronic illness, cancer, sleep disorders, chronic pain conditions, and neurodevelopmental disorders. Study procedures were approved by the local institutional review board and carried out in accordance with guidelines for the ethical conduct of research. Written informed consent was obtained from each caregiver participant, while assent was obtained from children age !7 years.
Procedures
All caregivers and children in this study were given a packet of study measures addressing the child's frequency of epigastric pain experiences and their severity, internalizing symptoms including depressive symptoms and anxiety, as well as sleep habits. Study measures were primarily completed by caregivers. Demographic information was collected from all children and included age, sex, and racial background. For children with EoE, pertinent clinical data including duration of illness and type of treatment regimen were obtained through medical record review. Additionally, both children with EoE and healthy controls completed 12 consecutive nights of ambulatory sleep monitoring via actigraphy in the home environment. After 12 days, the actigraphic sleep monitoring device was returned to the investigators via U.S. postal service, and participants were subsequently compensated with a $20 Visa gift card.
Study Measures
PedsQL Eosinophilic Esophagitis Module-Symptom Scale I The PedsQL Eosinophilic Esophagitis ModuleSymptom Scale I is embedded within the larger 33-item measure assessing EoE clinical symptoms and treatments that affect health-related quality of life. Included in Symptom Scale I is an item that asks about the presence of chest pain and another item that asks about the presence of abdominal pain. Caregivers reported how frequently their child experienced chest and abdominal pain over the past month using the following response options: "never," "almost never," "sometimes," "often," and "almost always." In an effort to provide consistency across the study age-range, only caregiver-proxy report of symptoms is included.
In this study, children whose caregivers indicated that they experienced chest pain, abdominal pain, or both with a frequency of "often" or "almost always" in the past month were categorized as experiencing persistent pain. Children for whom their caregivers reported the frequency of their chest and abdominal pain experiences as "sometimes," "almost never," and "never" were categorized as not experiencing persistent pain. Pain was used as a categorical variable in this study because of the fundamental difference between the experience of persistent pain and occasional pain. Chest and abdominal pain experiences are collectively referred to as epigastric pain throughout this study.
Pain Severity Ratings
At the time of study recruitment, all children with EoE and healthy controls were asked to rate the severity of any current pain they were experiencing as well as the severity of the worst pain they experienced over the past week. Children responded using the Wong-Baker FACES scale and its associated 0-10 numeric rating scale, whereby 0 ¼ no hurt/no pain and 10 ¼ hurts worst/worst pain imaginable (Wong-Baker FACES Foundation, 2016). Children were told they could use any face/number on the scale that they felt best captured their (epigastric) pain experiences. Caregivers recorded their child's verbalized ratings of current pain and worst pain over the past week.
Short Mood and Feelings Questionnaire for Children
The Short Mood and Feelings Questionnaire (SMFQ) for children is a 13-item brief depressive symptom screening tool adapted from the original 33-item measure for youth age more than or equal to 8 years. This measure was used outside of the originally validated age range. The items included in the SMFQ for children address affective and cognitive symptoms of depression. Caregivers rated whether the provided phrases (e.g., "S/he felt miserable or unhappy") are indicative of their child's feelings and actions over the past 2 weeks using the following responses: "Not True," "Sometimes," or "True." Scores on the SMFQ for children range from 0 to 26, with higher scores suggestive of greater depressive symptoms. The SMFQ for children has good internal consistency with a Cronbach's alpha of 0.85 (Angold et al., 1995) , and caregiver-proxy reports on the SMFQ for children have previously been shown to be valid for measuring depressive symptoms in pediatric populations (Rhew et al., 2010; Thapar, Harold, & McGuffin, 1998) .
Screen for Child Anxiety-Related Emotional Disorders
The Screen for Child Anxiety-Related Emotional Disorders (SCARED) is a measure of childhood anxiety symptoms that consists of 41 items and 5 factors paralleling the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition classifications of generalized anxiety disorder, separation anxiety disorder, panic disorder, social anxiety disorder, and significant school avoidance (Birmaher et al., 1997) . In this study, caregivers rated the extent to which the items on the SCARED captured their child's experience with each anxiety symptom (e.g., my child is a worrier) using the following choice options: "Not true or hardly ever true," "Somewhat true or sometimes true," or "Very true or often true." An overall score for the SCARED was obtained by summing across all items. Overall scores on the SCARED can range from 0 to 82, with higher scores suggestive of more pervasive childhood anxiety symptoms. The caregiver-proxy report version of the SCARED is valid for youth age more than or equal to 8 years and has good internal consistency with Cronbach's alphas >0.70 on all scales (Muris, Dreessen, Bogels, Weckx, & van Melick, 2004) . This measure was used outside of the validated age range.
Child's Sleep Habits Questionnaire
The Child's Sleep Habits Questionnaire (CSHQ) is a 33-item caregiver-proxy report measure that is used to examine sleep habits and behaviors in children (Owens, Spirito, & McGuinn, 2000) . The CSHQ evaluates children's sleep according to behaviors within eight different domains including: bedtime resistance, sleep onset delay, sleep duration, sleep anxiety, night wakings, parasomnias, sleep-disordered breathing, and daytime sleepiness. Caregivers indicate the frequency with which their child has engaged in these sleep-related behaviors over a "typical" recent week. Items are rated on a three-point scale: "usually" if the sleep behavior occurred five to seven times/week; "sometimes" for two to four times/week; and "rarely" for zero to one time/week. Higher scores on each sleep domain suggest worse sleep habits and behavior. The CSHQ has been found to possess adequate and acceptable psychometric properties (Owens et al., 2000) .
Actigraphic Sleep Monitoring
Objective sleep data were obtained directly from children using actigraphy (Philips Respironics Actiwatch Spectrum, Bend, OR), which involves continuously wearing a watch-like device on the nondominant wrist. The actigraph was worn for 12 consecutive days following study enrollment. The actigraph is a solidstate accelerometer, or movement detector, designed to measure ambulatory activity and used to measure daily sleep-wake patterns and record body movement. Actigraphy has been shown to be comparable with polysomnography in identifying sleep disturbances and patterns consistent with insomnia (Blackwell et al., 2008; Kushida et al., 2001 ). Furthermore, actigraphic sleep monitoring yields valid data in children with and without persistent pain (Ward, Lentz, Kieckhefer, & Landis, 2012) . Bedtime and final awakening were obtained through corresponding sleep diaries completed with caregiver assistance. Sleep diaries were evaluated according to recommendations provided by Carney et al. (2012) . With the aid of these diaries, researchers used a protocol for actigraphy scoring and set sleep periods. Sleep-wake patterns were extracted from the actigraphy data using the Actiware software (Philips Respironics, Bend, OR), which bases its algorithm on the amplitude and frequency of detected movements scored in 30-s epochs.
The following parameters were derived from the actigraphy data and used for analytic purposes: wake after sleep onset, total sleep time, and sleep efficiency. The mean of each parameter was calculated across the 12 nights of actigraphy to obtain average nightly estimates. Wake after sleep onset was calculated by adding the number of minutes in which children were awake following sleep onset to final awakening. Total sleep time was scored as sleep in minutes from sleep onset to final awakening. Sleep efficiency is the ratio of estimated total sleep time divided by total time spent in bed, with values closer to 100% indicating the most efficient sleep.
Data Analysis
All participants provided complete demographic and questionnaire data; however, a small portion of missing data existed for some of the actigraphic sleep measures (<5%). The missing data did not systematically vary between EoE groups and controls, and were deemed to be missing at random. Therefore, a simple data imputation method was completed using the macro for Hot Deck imputation. This data imputation method is well validated, readily accepted in the statistical community, and resulted in complete data for all of the study participants. Descriptive data for the sample are reported separately as either percentages or Ms and SDs for the three study groups: (1) EoE with persistent pain, (2) EoE without persistent pain, and (3) controls. Differences in descriptive data between the three groups were assessed using chisquare tests for categorical variables and analysis of variance for continuous variables. Pearson correlations were used to examine zero-order relationships. Differences in pain severity, actigraphic sleep, and caregiver-proxy reported sleep adjusted for covariates were examined using analysis of covariance with post hoc analyses for pairwise comparisons. Statistical adjustments for multiple comparisons and inflated family-wise error rates were used using a Holm-Bonferroni procedure to obtain corrected p values. Results include the partial eta squared (g p 2 ) as a measure of effect size where appropriate. Following the conventions of Cohen (1988) , g p 2 ¼ 0.01 is considered a small effect, g p 2 ¼ 0.06 a medium-sized effect and g p 2 ¼0.14 a large effect. Observed power is also provided for all analyses. All analyses were carried out using SPSS, version 23.
Results
Participant Characteristics
Participant characteristics are shown in Table I . Of the 50 children with EoE recruited for this study, 24 (48%) reported experiencing persistent epigastric pain. The remaining 26 (52%) of children with EoE denied experiencing persistent pain. Further, all 25 control children without EoE also denied experiencing persistent pain. The mean age of the sample was 8.68 years (SD ¼ 2.68) and did not significantly differ across groups. The sample was comprised mostly of boys (72%), and 81.3% of participants were Caucasian (the remaining 18.7% were African-American). Sex and race distributions did not significantly differ across groups. The mean duration of EoE was 11.29 months (SD ¼ 19.24) and did not significantly differ between EoE with and without persistent pain. Children with EoE were primarily treated with either medication or a combination of medication and dietary restrictions. Type of treatment regimen did not significantly differ between EoE with and without persistent pain.
Caregiver-proxy reports of depressive symptoms (F 2,72 ¼ 4.69, p ¼ .012) and anxiety (F 2,72 ¼ 7.54, p ¼ .001) were found to significantly differ across groups. Post hoc analyses revealed that caregivers of children with EoE and persistent pain reported greater depressive symptoms (p ¼ .009) and anxiety (p ¼ .001) compared with controls. Depressive symptoms and anxiety did not significantly differ between children with EoE with and without persistent pain.
Covariates Across the entire sample, increasing age was significantly associated with less total sleep time on actigraphy (r ¼ À.43, p < .001). Girls reported significantly greater current pain severity than boys (F 1,73 ¼ 4.14, p ¼ .046). The difference in current pain severity between African-American and Caucasian children approached significance (F 1,73 ¼ 3.64, p ¼ .06). Further, caregiver-proxy reports of children's anxiety were significantly associated with greater current pain severity (r ¼ .31, p ¼ .006), greater worst pain severity over the past week (r ¼ .24, p ¼ .037), and less total sleep time on actigraphy (r ¼ À.26, p ¼ .022). Caregiver-proxy reports of children's depressive symptoms were associated with greater daytime sleepiness on the sleep questionnaire (r ¼ .41, p < .001). In all subsequent data analysis, age, sex (coded 0 ¼ female, 1 ¼ male), and race (coded 0 ¼ Caucasian, 1 ¼ African-American), as well as caregiver-proxy reports of anxiety and depressive symptoms were each included as covariates. Pain severity, actigraphic sleep, and caregiver-proxy reports of sleep were not related to duration of EoE diagnosis, and did not significantly differ according to type of EoE treatment regimen. Therefore, duration of EoE diagnosis and treatment regimen were not included as covariates.
Pain Severity
As demonstrated in Table II , there were significant group differences revealed for ratings of current pain severity (F 2,67 ¼ 11.51, p < .001; g p 2 ¼ 0.256; observed power ¼ 0.992) and worst pain over the past week (F 2,67 ¼ 15.73, p < .001, g p 2 ¼ 0.319; observed power ¼ 0.999) . Children with EoE and persistent pain reported significantly greater current pain severity compared with children with EoE and no persistent pain (p ¼ .004) as well as controls (p < .001).
Similarly, reports of worst pain over the past week were significantly greater for children with EoE and persistent pain compared with children with EoE and no persistent pain (p ¼ .004) as well as controls (p < .001).
Actigraphic Sleep
Group differences in actigraphic sleep are presented in Table III EoE with persistent pain > EoE without persistent pain and healthy controls. efficiencies <85% compared with EoE without persistent pain (11%) and controls (8%) (v 2 ¼ 6.42, p ¼ .041). 
Caregiver-Proxy Reports of Sleep
Discussion
Dysphagia, food impaction, and nausea/vomiting are often described in the literature as the most common symptoms of EoE in children (Dauer, Freese, ElYoussef, & Thompson, 2005) . However, it is becoming increasingly apparent that many of these children are also experiencing persistent epigastric pain that is related to their EoE. What is perhaps more concerning is that while other symptoms often remit with successful treatment of EoE, the experience of epigastric pain continues. Persistent pain that is not adequately treated can have significant consequences for other aspects of health and well-being. For instance, the presence of pain, even when only mildly severe, can disturb sleep and decrease its quality (Finan et al., 2013) . Our group has previously suggested that additional research is needed to better understand the nature of any sleep difficulties experienced by children with EoE, particularly those with persistent epigastric pain (Lynch et al., 2015) . To our knowledge, the current study is the first to demonstrate that children with EoE who experience persistent epigastric pain show evidence of significantly disturbed sleep on actigraphy. Further, the severity of epigastric pain ranged from mild to severe when children were asked to rate their current pain and worst pain over the past week.
When compared with healthy controls and EoE without persistent pain, a significantly greater proportion of children with EoE who were experiencing persistent pain had average nightly actigraphic sleep efficiencies <85%. This is particularly noteworthy because nightly sleep efficiency <85% is clinically relevant and suggestive of insomnia (Hysing, Pallesen, Stormark, Lundervold, & Sivertsen, 2013) . Children with EoE and persistent pain also had greater actigraphic wake after sleep onset than their healthy peers. Furthermore, caregivers of children with EoE and persistent pain reported that their children experienced more severe daytime sleepiness, and were more likely to fall asleep during daytime activities, than healthy controls. It seems likely that this daytime sleepiness is attributable to pain-related sleep disturbances at night rather than some other cause such as obstructive sleep apnea. This is because caregivers of children with EoE and persistent pain indicated that their children demonstrated less sleep disorder breathing in comparison with controls. Consideration of the differences in sleep needs across childhood and adolescence is warranted to more fully understand the sleep of children with EoE and persistent pain. Furthermore, it is worth considering whether the daytime sleepiness experienced by children with EoE and persistent pain might be better explained as fatigue, a multidimensional concept that includes physical exhaustion, emotional disturbances, decreased motivation, and cognitive capacity. Fatigue has previously been shown to be an important correlate of pain and sleep disturbances in children with a chronic pain condition (Ward et al., 2008) .
Persistent pain and poor sleep can negatively impact children in a multitude of domains including executive functioning (Berryman et al., 2014; Kuula et al., 2015; Nes, Roach, & Segerstrom, 2009; Turnbull, Reid, & Morton, 2013) , memory formation (Curcio, Ferrara, & De Gennaro, 2006; Hart, Wade, & Martelli, 2003) , academic performance (Dewald, Meijer, Oort, Kerkhof, & Bogels, 2010; Dick & Riddell, 2010) , social engagement (Forgeron et al., 2010 (Forgeron et al., , 2011 Vaughn, Elmore-Staton, Shin, & ElSheikh, 2015) , and quality of life (Gold et al., 2009; Hunfeld et al., 2001; Magee, Gordon, & Caputi, 2014) . Furthermore, the relationship between persistent pain and sleep is often a vicious cycle, whereby pain begets sleep disturbances, and in turn, disturbed sleep can lead to increased pain severity (Palermo, Fonareva, & Janosy, 2008) . Recent research suggests that poor sleep may be more predictive of next day pain than daytime pain is of sleep disturbance (Lewandowski, Palermo, De la Motte, & Fu, 2010) . The current study's findings suggest that assessment of pain symptoms and sleep should be routinely incorporated into the clinical evaluation of children with EoE. Whether the inclusion of appropriate pain and sleep management treatments results in improved clinical care for children with EoE represents an important topic in need for greater attention moving forward.
Poor psychological functioning is known to be strongly associated with pain and sleep disturbances in children (Palermo & Kiska, 2005) . Caregivers of children with EoE and persistent pain in this study reported observing significantly greater symptoms of anxiety and depression in their children compared with healthy controls. This finding is consistent with a previous study that reported 69% of children with EoE experienced some form of problem suggestive of poor psychological functioning, ranging from social and school difficulties to depression and anxiety (Harris et al., 2013 ). Children's anxiety symptoms, as reported by caregivers, were significantly associated with greater current pain severity, greater worst pain severity over the past week, and less total sleep time on actigraphy. At this time, it remains unclear whether internalizing symptoms like anxiety and depression represent a determinant or consequence of persistent pain and disturbed sleep in children with EoE; additional research on this topic is warranted. However, it stands to reason that treatments designed to promote pain relief and the maintenance of adequate sleep in children with EoE may also yield improvements in psychological functioning by decreasing anxiety and depression (Clarke et al., 2015; Palermo et al., 2016; Pigeon et al., 2012; Valrie, Bromberg, Palermo, & Schanberg, 2013) .
Several study limitations should be considered when interpreting these findings. First, the relatively small number of children with EoE and persistent pain (n ¼ 24) limited our ability to examine associations among pain severity, sleep, and internalizing symptoms specifically within this group. Thus, it remains to be determined whether severity of pain is significantly associated with severity of sleep disturbances and internalizing symptoms in children with EoE and persistent epigastric pain. Additionally, the sample is limited to those without diagnosed sleep or pain conditions. This may limit the ability to generalize these findings to more medically complex patients. Second, this study relied on caregiver-proxy reports of internalizing symptoms and sleep patterns. While the measures included in this study report strong concordance between caregiver-proxy and child self-reports, future studies should consider ways to collect both caregiverproxy and child self-reports for all domains of interest. Furthermore, the anxiety and depression measures used in this study have not been validated in children as young as 4 years of age. Therefore, only tentative conclusions can be drawn regarding the relationships between these variables. The cross-sectional design of this study does not allow for the establishment of a temporal precedence regarding the development of persistent pain and sleep disturbances in children with EoE. Whether persistent pain more reliably predicts the development of sleep disturbances or vice versa remains to be determined. A longitudinal study following children monitoring children with EoE from the time of first diagnosis would be able to better discern aspects of directionality when it comes to the associations among pain, sleep, and internalizing symptoms. Finally, unknown or unmeasured factors may have also contributed to the findings.
In conclusion, this study provides novel evidence that a significant proportion of children with EoE experience persistent symptoms of epigastric pain that range in severity from mild to severe. Further, these children with EoE and persistent pain also experience more disturbed sleep than both their healthy peers and other children with EoE who do not experience persistent pain. Consistent with what has been reported in previous studies (Flood et al., 2008; Straumann et al., 2012) , our findings suggest that epigastric pain, disturbed sleep, and internalizing symptoms (i.e., anxiety and depression) are clinically important and interrelated symptoms that commonly affect children with EoE. Consensus treatment guidelines for EoE in children tend to focus primarily on reducing the number of eosinophils in the esophagus in an effort to minimize dysphagia, nausea/vomiting, reflux, food impactions, and the development of fibrosis (Dellon et al., 2013; Liacouras et al., 2011) . However, persistent pain, sleep problems, and internalizing symptoms do not appear to be regular targets for intervention in children with EoE. This may result in missed opportunities to improve the quality of life in this pediatric patient population.
Fortunately, psychologically based therapies have demonstrated efficacy for improving pediatric pain (Fisher et al., 2014) , sleep (Sadeh, 2005) , and mood (Hofmann, Asnaani, Vonk, Sawyer, & Fang, 2012) outcomes without the added burden of additional treatment side effects. Moving forward, integration of developmentally appropriate psychological services in pediatric gastroenterology clinics is recommended to provide evaluation of the child's pain experience, and screening for disordered sleep and internalizing symptoms. Additionally, providing education, brief problem-focused intervention, and referrals for outside services as necessary would serve to more comprehensively address the treatment needs of children with EoE. 
